These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 5-Hydroxymethylfurfural inhibits Acinetobacter baumannii biofilms: an in vitro study. Vijayakumar K; Thirunanasambandham R Arch Microbiol; 2021 Mar; 203(2):673-682. PubMed ID: 33037454 [TBL] [Abstract][Full Text] [Related]
6. Modulating the development of E. coli biofilms with 2-aminoimidazoles. Reed CS; Huigens RW; Rogers SA; Melander C Bioorg Med Chem Lett; 2010 Nov; 20(21):6310-2. PubMed ID: 20846860 [TBL] [Abstract][Full Text] [Related]
7. Identification of aryl 2-aminoimidazoles as biofilm inhibitors in Gram-negative bacteria. Bunders CA; Richards JJ; Melander C Bioorg Med Chem Lett; 2010 Jun; 20(12):3797-800. PubMed ID: 20466544 [TBL] [Abstract][Full Text] [Related]
8. Biofilm inhibitory efficiency of phytol in combination with cefotaxime against nosocomial pathogen Acinetobacter baumannii. Ramanathan S; Arunachalam K; Chandran S; Selvaraj R; Shunmugiah KP; Arumugam VR J Appl Microbiol; 2018 Jul; 125(1):56-71. PubMed ID: 29473983 [TBL] [Abstract][Full Text] [Related]
9. Chemical shift assignments and secondary structure prediction of the C-terminal domain of the response regulator BfmR from Acinetobacter baumannii. Olson AL; Thompson RJ; Melander C; Cavanagh J Biomol NMR Assign; 2014 Apr; 8(1):67-70. PubMed ID: 23264007 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Acinetobacter baumannii biofilm formation on a methacrylate polymer containing a 2-aminoimidazole subunit. Peng L; DeSousa J; Su Z; Novak BM; Nevzorov AA; Garland ER; Melander C Chem Commun (Camb); 2011 May; 47(17):4896-8. PubMed ID: 21442111 [TBL] [Abstract][Full Text] [Related]
11. Enhancing pili assembly and biofilm formation in Acinetobacter baumannii ATCC19606 using non-native acyl-homoserine lactones. Luo LM; Wu LJ; Xiao YL; Zhao D; Chen ZX; Kang M; Zhang Q; Xie Y BMC Microbiol; 2015 Mar; 15():62. PubMed ID: 25888221 [TBL] [Abstract][Full Text] [Related]
12. High throughput virtual screening and molecular dynamics simulation analysis of phytomolecules against BfmR of Lokhande KB; Pawar SV; Madkaiker S; Nawani N; Venkateswara SK; Ghosh P J Biomol Struct Dyn; 2023 Apr; 41(7):2698-2712. PubMed ID: 35156902 [No Abstract] [Full Text] [Related]
13. Inhibitory effect of α-mangostin on Acinetobacter baumannii biofilms - an in vitro study. Sivaranjani M; Srinivasan R; Aravindraja C; Karutha Pandian S; Veera Ravi A Biofouling; 2018 May; 34(5):579-593. PubMed ID: 29869541 [TBL] [Abstract][Full Text] [Related]
14. Structural studies on 4,5-disubstituted 2-aminoimidazole-based biofilm modulators that suppress bacterial resistance to β-lactams. Su Z; Yeagley AA; Su R; Peng L; Melander C ChemMedChem; 2012 Nov; 7(11):2030-9. PubMed ID: 23011973 [TBL] [Abstract][Full Text] [Related]
15. Effects of N-pyrrole substitution on the anti-biofilm activities of oroidin derivatives against Acinetobacter baumannii. Richards JJ; Reed CS; Melander C Bioorg Med Chem Lett; 2008 Aug; 18(15):4325-7. PubMed ID: 18625555 [TBL] [Abstract][Full Text] [Related]
16. Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump. He X; Lu F; Yuan F; Jiang D; Zhao P; Zhu J; Cheng H; Cao J; Lu G Antimicrob Agents Chemother; 2015 Aug; 59(8):4817-25. PubMed ID: 26033730 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of 4,5-disubstituted-2-aminoimidazole-triazole conjugates for antibiofilm/antibiotic resensitization activity against MRSA and Acinetobacter baumannii. Su Z; Peng L; Worthington RJ; Melander C ChemMedChem; 2011 Dec; 6(12):2243-51. PubMed ID: 21928438 [TBL] [Abstract][Full Text] [Related]
18. Antibiofilm and antivirulence efficacy of myrtenol enhances the antibiotic susceptibility of Acinetobacter baumannii. Selvaraj A; Valliammai A; Sivasankar C; Suba M; Sakthivel G; Pandian SK Sci Rep; 2020 Dec; 10(1):21975. PubMed ID: 33319862 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the Different Stages of Biofilm Formation and Antibiotic Susceptibility in a Clinical Da Cunda P; Iribarnegaray V; Papa-Ezdra R; Bado I; González MJ; Zunino P; Vignoli R; Scavone P Microb Drug Resist; 2020 Jun; 26(6):569-575. PubMed ID: 31895639 [No Abstract] [Full Text] [Related] [Next] [New Search]